The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Defining the clinical course of multiple sclerosis: Results of an international survey
Abstract
Standardization of terminology used to describe the pattern and course of MS is essential for mutual understanding between clinicians and investigators. It is particularly important in design of, and recruitment for, clinical trials statistically powered for expected outcomes for given patient populations with narrowly defined entry criteria. For agents that prove safe and effective for MS, knowledge of the patient populations in definitive clinical trials assists clinicians in determining who may ultimately benefit from use of the medication. An international survey of clinicians involved with MS revealed areas of consensus about some terms classically used to describe types of the disease and other areas for which there was lack of consensus. In this report, we provide a summary of the survey results and propose standardized definitions for the most common clinical courses of patients with MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schumacher, G. A., Beebe, G., Kibler, R. F., Kurland, L. T., Kurtzke, J. F., McDowell, F., Nagler, B., Sibley, W. A., Tourtellotte, W. W., & Willmon, T. L. (1965) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1965.tb20235.x · Cited by 1,438
Major differences in the dynamics of primary and secondary progressive multiple sclerosis
Thompson, A. J., Kermode, A. G., Wicks, D., MacManus, D. G., Kendall, B. E., Kingsley, D. P. E., & McDonald, W. I. (1991) · Annals of Neurology · doi:10.1002/ana.410290111 · Cited by 486
SERIAL GADOLINIUM ENHANCED MAGNETIC RESONANCE IMAGING IN MULTIPLE SCLEROSIS
MILLER, D. H., RUDGE, P., JOHNSON, G., KENDALL, B. E., MACMANUS, D. G., MOSELEY, I. F., BARNES, D., & MCDONALD, W. I. (1988) · Brain · doi:10.1093/brain/111.4.927 · Cited by 407
Autosomal dominant cerebellar phenotypes: The genotype has settled the issue
Rosenberg, R. N. (1995) · Neurology · doi:10.1212/wnl.45.1.1 · Cited by 402
Megadose corticosteroids in multiple sclerosis
Kupersmith, M. J., Kaufman, D., Paty, D. W., Ebers, G., McFarland, H., Johnson, K., Reingold, S., & Whitaker, J. (1994) · Neurology · doi:10.1212/wnl.44.1.1 · Cited by 386
Self-citationEDMUS, a European database for multiple sclerosis.
Confavreux, C., Compston, D. A., Hommes, O. R., McDonald, W. I., & Thompson, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.8.671 · Cited by 313
NAESER, M. A., PALUMBO, C. L., HELM-ESTABROOKS, N., STIASSNY-EDER, D., & ALBERT, M. L. (1989) · Brain · doi:10.1093/brain/112.1.1 · Cited by 298
Willoughby, E. W., Grochowski, E., Li, D. K. B., Oger, J., Kastrukoff, L. F., & Paty, D. W. (1989) · Annals of Neurology · doi:10.1002/ana.410250107 · Cited by 254
Outcomes assessment in multiple sclerosis clinical trials: a critical analysis
Whitaker, J., McFarland, H., Rudge, P., & Reingold, S. (1995) · Multiple Sclerosis Journal · doi:10.1177/135245859500100107 · Cited by 236
Self-citationDuchenne muscular dystrophy: High frequency of deletions
Bartlett, R. J., Pericak-Vance, M. A., Koh, J., Yamaoka, L. H., Chen, J. C., Hung, W. Y., Speer, M. C., Wapenaar, M. C., B. Van Ommen, G. J., Bakker, E., et al. (1988) · Neurology · doi:10.1212/wnl.38.1.1 · Cited by 196
Cited by
Items 101–200 of 217
Mohr, D. C., Boudewyn, A. C., Goodkin, D. E., Bostrom, A., & Epstein, L. (2001) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.69.6.942 · Cited by 334
Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography
Saidha, S., Syc, S. B., Ibrahim, M. A., Eckstein, C., Warner, C. V., Farrell, S. K., Oakley, J. D., Durbin, M. K., Meyer, S. A., Balcer, L. J., et al. (2011) · Brain · doi:10.1093/brain/awq346 · Cited by 333
Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes
Ruano, L., Portaccio, E., Goretti, B., Niccolai, C., Severo, M., Patti, F., Cilia, S., Gallo, P., Grossi, P., Ghezzi, A., et al. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458516674367 · Cited by 331
Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging
Haacke, E. M., Makki, M., Ge, Y., Maheshwari, M., Sehgal, V., Hu, J., Selvan, M., Wu, Z., Latif, Z., Xuan, Y., et al. (2009) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21676 · Cited by 329
Revised diagnostic criteria of multiple sclerosis
Milo, R., & Miller, A. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.01.012 · Cited by 326
A secondary progressive clinical course is uncommon in neuromyelitis optica
Wingerchuk, D. M., Pittock, S. J., Lucchinetti, C. F., Lennon, V. A., & Weinshenker, B. G. (2007) · Neurology · doi:10.1212/01.wnl.0000254502.87233.9a · Cited by 326
Werring, D. J. (2000) · Brain · doi:10.1093/brain/123.8.1667 · Cited by 326
Default-mode network dysfunction and cognitive impairment in progressive MS
Rocca, M. A., Valsasina, P., Absinta, M., Riccitelli, G., Rodegher, M. E., Misci, P., Rossi, P., Falini, A., Comi, G., & Filippi, M. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d9ed91 · Cited by 323
Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes
De Stefano, N., Giorgio, A., Battaglini, M., Rovaris, M., Sormani, M. P., Barkhof, F., Korteweg, T., Enzinger, C., Fazekas, F., Calabrese, M., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e24136 · Cited by 321
Keegan, B. M., & Noseworthy, J. H. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103909 · Cited by 319
Demyelination versus remyelination in progressive multiple sclerosis
Bramow, S., Frischer, J. M., Lassmann, H., Koch-Henriksen, N., Lucchinetti, C. F., Sørensen, P. S., & Laursen, H. (2010) · Brain · doi:10.1093/brain/awq250 · Cited by 319
Shu, N., Liu, Y., Li, K., Duan, Y., Wang, J., Yu, C., Dong, H., Ye, J., & He, Y. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhr039 · Cited by 315
Classification, diagnosis, and differential diagnosis of multiple sclerosis
Katz Sand, I. (2015) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000206 · Cited by 315
Schulz, K.-H., Gold, S. M., Witte, J., Bartsch, K., Lang, U. E., Hellweg, R., Reer, R., Braumann, K.-M., & Heesen, C. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.06.009 · Cited by 314
Foley, P. L., Vesterinen, H. M., Laird, B. J., Sena, E. S., Colvin, L. A., Chandran, S., MacLeod, M. R., & Fallon, M. T. (2013) · Pain · doi:10.1016/j.pain.2012.12.002 · Cited by 310
Calabrese, M., De Stefano, N., Atzori, M., Bernardi, V., Mattisi, I., Barachino, L., Morra, A., Rinaldi, L., Romualdi, C., Perini, P., et al. (2007) · Archives of Neurology · doi:10.1001/archneur.64.10.1416 · Cited by 309
fMRI evidence of brain reorganization during attention and memory tasks in multiple sclerosis
Mainero, C., Caramia, F., Pozzilli, C., Pisani, A., Pestalozza, I., Borriello, G., Bozzao, L., & Pantano, P. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2003.10.004 · Cited by 306
Secondary progressive multiple sclerosis: current knowledge and future challenges
Rovaris, M., Confavreux, C., Furlan, R., Kappos, L., Comi, G., & Filippi, M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70410-0 · Cited by 303
Association between clinical disease activity and Epstein–Barr virus reactivation in MS
Wandinger, K.-P., Jabs, W., Siekhaus, A., Bubel, S., Trillenberg, P., Wagner, H.-J., Wessel, K., Kirchner, H., & Hennig, H. (2000) · Neurology · doi:10.1212/wnl.55.2.178 · Cited by 302
An altered immune response to Epstein-Barr virus in multiple sclerosis: A prospective study
Sundström, P., Juto, P., Wadell, G., Hallmans, G., Svenningsson, A., Nyström, L., Dillner, J., & Forsgren, L. (2004) · Neurology · doi:10.1212/01.wnl.0000130496.51156.d7 · Cited by 301
Neocortical Atrophy, Third Ventricular Width, and Cognitive Dysfunction in Multiple Sclerosis
Benedict, R. H. B., Bruce, J. M., Dwyer, M. G., Abdelrahman, N., Hussein, S., Weinstock-Guttman, B., Garg, N., Munschauer, F., & Zivadinov, R. (2006) · Archives of Neurology · doi:10.1001/archneur.63.9.1301 · Cited by 301
Gold, S. M., Schulz, K.-H., Hartmann, S., Mladek, M., Lang, U. E., Hellweg, R., Reer, R., Braumann, K.-M., & Heesen, C. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00121-8 · Cited by 300
Measurement and clinical effect of grey matter pathology in multiple sclerosis
Geurts, J. J., Calabrese, M., Fisher, E., & Rudick, R. A. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70230-2 · Cited by 298
Saidha, S., Syc, S. B., Durbin, M. K., Eckstein, C., Oakley, J. D., Meyer, S. A., Conger, A., Frohman, T. C., Newsome, S., Ratchford, J. N., et al. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511418630 · Cited by 296
Grey Matter Pathology in Multiple Sclerosis
Vercellino, M., Plano, F., Votta, B., Mutani, R., Giordana, M. T., & Cavalla, P. (2005) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000190067.20935.42 · Cited by 295
The molecular basis of neurodegeneration in multiple sclerosis
Lassmann, H., & van Horssen, J. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.08.004 · Cited by 294
Cigarette smoking and the progression of multiple sclerosis
Hernán, M. A., Jick, S. S., Logroscino, G., Olek, M. J., Ascherio, A., & Jick, H. (2005) · Brain · doi:10.1093/brain/awh471 · Cited by 294
Cercignani, M. (2001) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.3.311 · Cited by 291
Onset of secondary progressive phase and long-term evolution of multiple sclerosis
Scalfari, A., Neuhaus, A., Daumer, M., Muraro, P. A., & Ebers, G. C. (2014) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304333 · Cited by 291
Validity of performance scales for disability assessment in multiple sclerosis
Marrie, R. A., & Goldman, M. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458507078388 · Cited by 285
Multiple Sclerosis: Immunopathology and Treatment Update
Dargahi, N., Katsara, M., Tselios, T., Androutsou, M.-E., De Courten, M., Matsoukas, J., & Apostolopoulos, V. (2017) · Brain Sciences · doi:10.3390/brainsci7070078 · Cited by 285
The Role of Natural Killer Cells in Autoimmune Diseases
Kucuksezer, U. C., Aktas Cetin, E., Esen, F., Tahrali, I., Akdeniz, N., Gelmez, M. Y., & Deniz, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.622306 · Cited by 284
The psychosocial impact of multiple sclerosis: Exploring the patient's perspective.
Mohr, D. C., Dick, L. P., Russo, D., Pinn, J., Boudewyn, A. C., Likosky, W., & Goodkin, D. E. (1999) · Health Psychology · doi:10.1037//0278-6133.18.4.376 · Cited by 284
MULTIPLE SCLEROSIS AND THE UROLOGIST
LITWILLER, S. E., FROHMAN, E. M., & ZIMMERN, P. E. (1999) · Journal of Urology · doi:10.1016/s0022-5347(01)61760-9 · Cited by 282
Quantitative magnetic resonance of postmortem multiple sclerosis brain before and after fixation
Schmierer, K., Wheeler‐Kingshott, C. A. M., Tozer, D. J., Boulby, P. A., Parkes, H. G., Yousry, T. A., Scaravilli, F., Barker, G. J., Tofts, P. S., & Miller, D. H. (2008) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21487 · Cited by 281
“The course of MS (22) and the disability of the patients were assessed retrospectively from the case records collected at the MSTB.”
MethodMR Imaging of Multiple Sclerosis
Filippi, M., & Rocca, M. A. (2011) · Radiology · doi:10.1148/radiol.11101362 · Cited by 281
Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant
Steenwijk, M. D., Geurts, J. J. G., Daams, M., Tijms, B. M., Wink, A. M., Balk, L. J., Tewarie, P. K., Uitdehaag, B. M. J., Barkhof, F., Vrenken, H., et al. (2016) · Brain · doi:10.1093/brain/awv337 · Cited by 281
Chard, D. T. (2002) · Brain · doi:10.1093/brain/awf240 · Cited by 280
Age and disability accumulation in multiple sclerosis
Scalfari, A., Neuhaus, A., Daumer, M., Ebers, G. C., & Muraro, P. A. (2011) · Neurology · doi:10.1212/wnl.0b013e318230a17d · Cited by 279
Comi, G., Pulizzi, A., Rovaris, M., Abramsky, O., Arbizu, T., Boiko, A., Gold, R., Havrdova, E., Komoly, S., Selmaj, K., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60918-6 · Cited by 278
Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS
Huijbregts, S. C. J., Kalkers, N. F., de Sonneville, L. M. J., de Groot, V., Reuling, I. E. W., & Polman, C. H. (2004) · Neurology · doi:10.1212/01.wnl.0000129828.03714.90 · Cited by 277
Bruce, J. M., Hancock, L. M., Arnett, P., & Lynch, S. (2010) · Journal of Behavioral Medicine · doi:10.1007/s10865-010-9247-y · Cited by 276
Quantitative magnetization transfer imaging in postmortem multiple sclerosis brain
Schmierer, K., Tozer, D. J., Scaravilli, F., Altmann, D. R., Barker, G. J., Tofts, P. S., & Miller, D. H. (2007) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20984 · Cited by 273
Tur, C., Carbonell-Mirabent, P., Cobo-Calvo, Á., Otero-Romero, S., Arrambide, G., Midaglia, L., Castilló, J., Vidal-Jordana, Á., Rodríguez-Acevedo, B., Zabalza, A., et al. (2023) · JAMA Neurology · doi:10.1001/jamaneurol.2022.4655 · Cited by 273
The Sonya Slifka Longitudinal Multiple Sclerosis Study: methods and sample characteristics
Minden, S. L., Frankel, D., Hadden, L., Perloff, J., Srinath, K. P., & Hoaglin, D. C. (2006) · Multiple Sclerosis Journal · doi:10.1191/135248506ms1262oa · Cited by 272
Digital Twins for Multiple Sclerosis
Voigt, I., Inojosa, H., Dillenseger, A., Haase, R., Akgün, K., & Ziemssen, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.669811 · Cited by 272
Epidemiology of Multiple Sclerosis
Howard, J., Trevick, S., & Younger, D. S. (2016) · Neurologic Clinics · doi:10.1016/j.ncl.2016.06.016 · Cited by 269
Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis
Tutuncu, M., Tang, J., Zeid, N. A., Kale, N., Crusan, D. J., Atkinson, E. J., Siva, A., Pittock, S. J., Pirko, I., Keegan, B. M., et al. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458512451510 · Cited by 267
Factors related to employment status changes in individuals with multiple sclerosis
Smith, M. M., & Arnett, P. A. (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1204oa · Cited by 264
The Role of Astrocytes in Multiple Sclerosis Progression
Correale, J., & Farez, M. F. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00180 · Cited by 261
New perspectives in the natural history of multiple sclerosis
Tremlett, H., Zhao, Y., Rieckmann, P., & Hutchinson, M. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e3973f · Cited by 261
Hawkins, S. A., & McDonnell, G. V. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.2.148 · Cited by 260
Neuropsychological Aspects of Multiple Sclerosis
Brassington, J. C., & Marsh, N. V. (1998) · Neuropsychology Review · doi:10.1023/a:1025621700003 · Cited by 258
Circulating MicroRNAs as biomarkers for disease staging in multiple sclerosis
Gandhi, R., Healy, B., Gholipour, T., Egorova, S., Musallam, A., Hussain, M. S., Nejad, P., Patel, B., Hei, H., Khoury, S., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23880 · Cited by 258
Body fluid biomarkers in multiple sclerosis
Comabella, M., & Montalban, X. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70233-3 · Cited by 258
Horsfield, M. A., Sala, S., Neema, M., Absinta, M., Bakshi, A., Sormani, M. P., Rocca, M. A., Bakshi, R., & Filippi, M. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2009.12.121 · Cited by 257
Rocca, M. A., Colombo, B., Falini, A., Ghezzi, A., Martinelli, V., Scotti, G., Comi, G., & Filippi, M. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70171-x · Cited by 254
Law, M., Saindane, A. M., Ge, Y., Babb, J. S., Johnson, G., Mannon, L. J., Herbert, J., & Grossman, R. I. (2004) · Radiology · doi:10.1148/radiol.2313030996 · Cited by 242
Mohr, D. C., Likosky, W., Bertagnolli, A., Goodkin, D. E., Van Der Wende, J., Dwyer, P., & Dick, L. P. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.2.356 · Cited by 240
Pathology and disease mechanisms in different stages of multiple sclerosis
Lassmann, H. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.05.010 · Cited by 224
Mechanisms of white matter damage in multiple sclerosis
Lassmann, H. (2014) · Glia · doi:10.1002/glia.22597 · Cited by 191
Ribbons, K. A., McElduff, P., Boz, C., Trojano, M., Izquierdo, G., Duquette, P., Girard, M., Grand’Maison, F., Hupperts, R., Grammond, P., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0122686 · Cited by 190
Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study
Manouchehrinia, A., Tench, C. R., Maxted, J., Bibani, R. H., Britton, J., & Constantinescu, C. S. (2013) · Brain · doi:10.1093/brain/awt139 · Cited by 184
Multiple sclerosis: Empirical literature for the clinical health psychologist
Mohr, D. C., & Cox, D. (2001) · Journal of Clinical Psychology · doi:10.1002/jclp.1042 · Cited by 176
Rissanen, E., Tuisku, J., Rokka, J., Paavilainen, T., Parkkola, R., Rinne, J. O., & Airas, L. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.131698 · Cited by 171
Mechanisms of Neurodegeneration and Axonal Dysfunction in Progressive Multiple Sclerosis
Correale, J., Marrodan, M., & Ysrraelit, M. C. (2019) · Biomedicines · doi:10.3390/biomedicines7010014 · Cited by 167
Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome
Kantarci, O. H., Lebrun, C., Siva, A., Keegan, M. B., Azevedo, C. J., Inglese, M., Tintoré, M., Newton, B. D., Durand‐Dubief, F., Amato, M. P., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24564 · Cited by 167
McCabe, M. P., & McKern, S. (2002) · Journal of Clinical Psychology in Medical Settings · doi:10.1023/a:1020734901150 · Cited by 166
Improved detection of cortical MS lesions with phase-sensitive inversion recovery MRI
Sethi, V., Yousry, T. A., Muhlert, N., Ron, M., Golay, X., Wheeler-Kingshott, C., Miller, D. H., & Chard, D. T. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303023 · Cited by 163
Dysferlin Is a New Marker for Leaky Brain Blood Vessels in Multiple Sclerosis
Hochmeister, S., Grundtner, R., Bauer, J., Engelhardt, B., Lyck, R., Gordon, G., Korosec, T., Kutzelnigg, A., Berger, J. J., Bradl, M., et al. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000235119.52311.16 · Cited by 160
Fainardi, E., Castellazzi, M., Bellini, T., Manfrinato, M. C., Baldi, E., Casetta, I., Paolino, E., Granieri, E., & Dallocchio, F. (2006) · Multiple Sclerosis Journal · doi:10.1191/135248506ms1274oa · Cited by 145
Sex differences in experimental autoimmune encephalomyelitis in multiple murine strains
Papenfuss, T. L., Rogers, C. J., Gienapp, I., Yurrita, M., McClain, M., Damico, N., Valo, J., Song, F., & Whitacre, C. C. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.01.018 · Cited by 152
Treatment of depression in multiple sclerosis: Review and meta-analysis.
Mohr, D. C., & Goodkin, D. E. (1999) · Clinical Psychology: Science and Practice · doi:10.1093/clipsy.6.1.1 · Cited by 155
Health status and quality of life of people with multiple sclerosis
L. Ford, E. G. (2001) · Disability and Rehabilitation · doi:10.1080/09638280010022090 · Cited by 130
Hart, S., Fonareva, I., Merluzzi, N., & Mohr, D. C. (2005) · Quality of Life Research · doi:10.1007/s11136-004-1364-z · Cited by 128
“Inclusion criteria were (a) a confirmed diagnosis MS [34]; (b) a relapsing–remitting or secondary progressive disease course confirmed by a neurologist [34, 35]; and (c) a score of at least 16 on the Beck depression inventory (BDI) [36] and a score of 16 or more on the Hamilton rating scale for depression [37], and (d…”
BackgroundProgressive multiple sclerosis
Bradl, M., & Lassmann, H. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0182-3 · Cited by 108
Bakshi, R., Dmochowski, J., Shaikh, Z. A., & Jacobs, L. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00477-4 · Cited by 107
In vivo evidence of glutamate toxicity in multiple sclerosis
Azevedo, C. J., Kornak, J., Chu, P., Sampat, M., Okuda, D. T., Cree, B. A., Nelson, S. J., Hauser, S. L., & Pelletier, D. (2014) · Annals of Neurology · doi:10.1002/ana.24202 · Cited by 100
Hanken, K., Eling, P., & Hildebrandt, H. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00264 · Cited by 92
Tsunoda, I., Kuang, L., Theil, D. J., & Fujinami, R. S. (2000) · Brain Pathology · doi:10.1111/j.1750-3639.2000.tb00272.x · Cited by 86
Zivadinov, R., Zorzon, M., Tommasi, M. A., Nasuelli, D., Bernardi, M., Monti-Bragadin, L., & Cazzato, G. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(03)00225-9 · Cited by 81
Starost, L., Lindner, M., Herold, M., Xu, Y. K. T., Drexler, H. C. A., Heß, K., Ehrlich, M., Ottoboni, L., Ruffini, F., Stehling, M., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02217-8 · Cited by 79
Meditation as an adjunct to the management of multiple sclerosis.
Levin, A. B., Hadgkiss, E. J., Weiland, T. J., & Jelinek, G. A. (2014) · Neurology Research International · doi:10.1155/2014/704691 · Cited by 77
Alschuler, K. N., & Beier, M. L. (2015) · International Journal of MS Care · doi:10.7224/1537-2073.2014-044 · Cited by 76
Bogosian, A., Hughes, A., Norton, S., Silber, E., & Moss‐Morris, R. (2016) · British Journal of Health Psychology · doi:10.1111/bjhp.12201 · Cited by 75
Kallaur, A. P., Oliveira, S. R., Simão, A. N. C., Alfieri, D. F., Flauzino, T., Lopes, J., de Carvalho Jennings Pereira, W. L., de Meleck Proença, C., Borelli, S. D., Kaimen-Maciel, D. R., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-9846-x · Cited by 75
The prevalence of multiple sclerosis in 3 US communities.
(2010) · PubMed Central · Cited by 75
Quality of life in multiple sclerosis: influence of interferon-β1a (Avonex®) treatment
Vermersch, P., de Seze, J., Delisse, B., Lemaire, S., & Stojkovic, T. (2002) · Multiple Sclerosis Journal · doi:10.1191/1352458502ms826oa · Cited by 74
Vermersch, P., Brieva-Ruiz, L., Fox, R. J., Paul, F., Ramio-Torrenta, L., Schwab, M., Moussy, A., Mansfield, C., Hermine, O., Maciejowski, M., et al. (2022) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001148 · Cited by 74
Predicting neuropsychological abnormalities in multiple sclerosis
Benedict, R. H. B., & Zivadinov, R. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.05.020 · Cited by 73
Overdiagnosis of multiple sclerosis and magnetic resonance imaging criteria
Nielsen, J. M., Korteweg, T., Barkhof, F., Uitdehaag, B. M. J., & Polman, C. H. (2005) · Annals of Neurology · doi:10.1002/ana.20632 · Cited by 72
Social support in multiple sclerosis: associations with quality of life, depression, and anxiety
Ratajska, A., Glanz, B. I., Chitnis, T., Weiner, H. L., & Healy, B. C. (2020) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2020.110252 · Cited by 66
Nogueira, L. A. C., Nóbrega, F. R., Lopes, K. N., Thuler, L. C. S., & Alvarenga, R. M. P. (2009) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2009000500006 · Cited by 63
Vitkova, M., Gdovinova, Z., Rosenberger, J., Szilasiova, J., Nagyová, I., Mikula, P., Krokavcova, M., Groothoff, J. W., & van Dijk, J. P. (2014) · Disability and health journal · doi:10.1016/j.dhjo.2014.05.004 · Cited by 63
Alexithymia in multiple sclerosis: Relationship with fatigue and depression
Bodini, B., Mandarelli, G., Tomassini, V., Tarsitani, L., Pestalozza, I., Gasperini, C., Lenzi, G. L., Pancheri, P., & Pozzilli, C. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2007.00969.x · Cited by 59
Sakuma, H. (2004) · Brain · doi:10.1093/brain/awh260 · Cited by 59
Disruption of neurite morphology parallels MS progression
Spanò, B., Giulietti, G., Pisani, V., Morreale, M., Tuzzi, E., Nocentini, U., Francia, A., Caltagirone, C., Bozzali, M., & Cercignani, M. (2018) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000502 · Cited by 58
Theranostic implications of nanotechnology in multiple sclerosis: a future perspective.
Singh, A. V., Khare, M., Gade, W. N., & Zamboni, P. (2012) · Autoimmune Diseases · doi:10.1155/2012/160830 · Cited by 58
Diagnosing multiple sclerosis at a later age: more than just progressive myelopathy
Bermel, R. A., Rae-Grant, A. D., & Fox, R. J. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510377334 · Cited by 46
Tilling, K., Lawton, M., Robertson, N., Tremlett, H., Zhu, F., Harding, K., Oger, J., & Ben-Shlomo, Y. (2016) · Health Technology Assessment · doi:10.3310/hta20810 · Cited by 43
Metadata
- Authors
- Lublin, F. D., Reingold, S. C., & National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis*
- Venue
- Neurology
- Published
- 1996-04
- Volume
- 46
- Issue
- 4
- Pages
- 907-911
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2087589796
- Cited by
- 3,686
- References
- 12
- FWCI
- 45.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.